Theme: Enhancing innovations in Cancer Diagnosis and treatment

Cancer Diagnostics 2016

Renowned Speakers

Cancer Diagnostics 2016

Conferenceseries LLC invites all the participants from all over the globe to attend ‘‘Cancer Diagnostics Conference and Expo’' during June 13-15, 2016 in Rome, Italy which includes prompt Keynote presentations, Oral talks, Poster presentations and Exhibitions.

Cancer Diagnostics 2016 is a global Cancer Conferences and Cancer Meeting which discuss about the latest and recent advancements in the diagnosis and the treatment of cancer and deals about various researches going on in cancer diagnostics. This Conference mainly focuses on Cancer associations , Cancer societies and Cancer Research Groups.

Track 1:  Cancer Diagnostics Market:

Advanced diagnostics technologies have achieved a reduction of 30% in reduction due to breast cancer. Hence, the imaging sector in the global Oncological diagnostics market will continue its everlasting in the foreseeable future. The world-wide Cancer Diagnostics Market can be segmented into blood cancer, kidney cancer, breast cancer, prostate cancer, pancreatic cancer, ovarian cancer, lung cancer, and liver cancer. The global cancer diagnostics market is mostly driven by enhancing the demand for lung cancer and breast cancer diagnosis. The Pulmonary cancer segment is leading the market, as it is the very popular type of cancer.  Cancer Diagnostics 2016 is a very prestigious gathering across global Cancer Conferences.

Recommended Conferences  Cancer Conferences| Cancer Meetings| Cancer Events:

7th International Conference on Molecular Biomarkers & Clinical Research November 28-30, 2016 Baltimore, USA; 4th International Conference on Blood Malignancies and Treatment April 18-20, 2016  Dubai, UAE; 2nd International Conference on Prostate Cancer and Treatment May 05-07, 2016 Chicago, USA; 2nd International Conference on Antimicrobial Agents and Chemotherapy June 06-07, 2016 Dallas, USA; International Conference on Pancreatic and Colorectal Cancer March 29-30, 2016 Atlanta USA; 11th Annual Biomarkers Congress February 25-26, 2016 Manchester, UK; 2016 ARRS Lung cancer Annual Meeting April 12-16, 2016 Los Angeles, USA; NEO 16-“New and Emerging Trends In Oncology Conferences 2016, February 10-12, 2016  Hyderabad, India; EMBO | EMBL Symposium: Tumor Microenvironment and Signaling April 3-6, 2016 Heidelberg, Germany; Cancer-2016 — International Conference on Cancer Therapy April 4-6, 2016 Baltimore, USA. The ALS Association, Association for Molecular Pathology, The International Society of Oncology and Biomarkers, American Society of Clinical Oncology, Cancer Research SocietyNational Cancer Institute at the National Institutes of Health, The Canadian Cancer Society, The Swedish Cancer Society, The British Association for Cancer Research, American Brain Tumor Association, German Society for Oncological Pharmacy

Track 2:  Cancer Diagnostics Types:

Mammogram is used to image and X-ray of the Breast. While screening mammograms are routinely administered to detect breast cancer in women who has no apparent signs, diagnostic systems are used after suspicious results on a screening mammogram has some symptoms of breast cancer alert the Oncologist to check that tissue.

An ultrasound wand is inserted in vagina and to see at the ovaries. An ultrasound produces sound waves that induces imaging of the ovaries, including cysts, and Oocytes. Researchers are currently studying whether this test can help with early detection of ovarian cancer.

A breast biopsy is a test that cut tissue fluid from the breast. The removed cells are tested under a microscope and later checked for whether there is breast cancer. Conferenceseries LLC organizes large number of Cancer Conferences globally across the Cancer associations and Cancer Research Organizations.

Recommended Conferences  Cancer Conferences| Cancer Meetings| Cancer Events:

2nd International Conference on Prostate Cancer and Treatment May 05-07, 2016 Chicago, USA; 4th International Conference on Blood Malignancies and Treatment April 18-20, 2016 Dubai, UAE; 2nd International Conference on Antimicrobial Agents and Chemotherapy June 06-07, 2016 Dallas, USA;7th International Conference on Molecular Biomarkers & Clinical Research November 28-30, 2016 Baltimore, USA; International Conference on Pancreatic and Colorectal Cancer March 29-30, 2016 Atlanta, USA; Personalized Diagnostics February 16-18, 2016 San Francisco, USA; International Conference on  Cancer Research, June 8-10, 2016 Lyon, France; American Society of Clinical Oncology Conferences 2017 Annual Meeting October 24-26, 2016 San Francisco, USA; Post Congress Symposium on Cancer Diagnostics May 28, 2016 Gothenberg, Sweden; Cancer-2016: A critical review on innovations in the cancer diagnosis and treatment Feb 22-24, 2016 Baltimore, USA. Affymetrix Inc , Agilent Technologies , Biomarker Pharmaceuticals Inc., Bristol-Myers Squibb Company , Roche Diagnostics Corporation, Global Lung Cancer Coalition (GLCC), Breast Cancer Welfare Association , Cancer Research Initiatives Foundation

Track 3: Cancer Screening Tests:

Prostate screening tests consists of Digital rectal exam (DRE) and Prostate-specific antigen (PSA) test.

Screening increases the capacity of detecting certain cancers early when they are most likely to be curable. Learn what screening tests the American Cancer associations suggests, when you should have them, and how they are covered under some types of cancer therapies.

Mammograms are used to analyses breast cancer in women who have no signs or symptoms of the disease. Cancer screening Oncolytic is an exciting, increasingly recognized discipline in cancer research which will be discussed in upcoming cancer conferences.

Recommended  Conferences  Cancer Conferences| Cancer Meetings| Cancer Events:

2nd  International Conference on Prostate Cancer and Treatment May 05-07, 2016 Chicago, USA; 4th International Conference on Blood Malignancies and Treatment April 18-20, 2016 Dubai, UAE; 2nd International Conference on Antimicrobial Agents and Chemotherapy June 06-07, 2016 Dallas, USA;7th International Conference on Molecular Biomarkers & Clinical Research November 28-30, 2016 Baltimore, USA; International Conference on Pancreatic and Colorectal Cancer March 29-30, 2016 Atlanta, USA; Personalized Diagnostics February 16-18, 2016 San Francisco, USA; International Conference on  Cancer Research, June 8-10, 2016 Lyon, France; American Society of Clinical Oncology Conferences 2017 Annual Meeting October 24-26, 2016 San Francisco, USA; Post Congress Symposium on Cancer Diagnostics May 28, 2016 Gothenberg, Sweden; Cancer-2016: A critical review on innovations in the cancer diagnosis and treatment Feb 22-24, 2016 Baltimore, USA. The ALS Association, Association for Molecular Pathology, The International Society of Oncology and Biomarkers, American Society of Clinical Oncology, Cancer Research SocietyNational Cancer Institute at the National Institutes of Health, The Canadian Cancer Society, The Swedish Cancer Society, The British Association for Cancer Research, American Brain Tumor Association, German Society for Oncological Pharmacy

Track 4: Cancer Radiology

Radiological tests can help physicians to find and treat some of cancers early. Early detection is important because when abnormal tissue or cell is found early, it may easier to treat. By the time symptoms appear, cancer may have begun to spread and is very difficult to treat. Several screening tests have been shown to detect cancer early and to decrease the chance of death from that cancer. Lung cancer was the most common cancer worldwide in men contributing nearly 17% of the total number cases diagnosed in 2012 and become an important topic for World Cancer Conferences.

Recommended Conferences  Cancer Conferences| Cancer Meetings| Cancer Events:

13th Asia-Pacific Oncologists Annual Meeting October17-19, 2016 Kuala Lumpur, Malaysia; Experts Meeting on Gynecologic Oncology May 19-21, 2016 San Antonio, USA; International Conference on Pancreatic and Colorectal Cancer March 29-30, 2016 Atlanta, USA;, 7th International Conference on Molecular Biomarkers & Clinical Research November 28-30, 2016 Baltimore, USA. International Conference on Leukemia and Bone marrow Transplantation November 10-12, 2016, Istanbul, Turkey; Personalized Diagnostics February 16-18, 2016 San Francisco, USA; International Conference on  Cancer Research, June 8-10, 2016 Lyon, France; American Society of Clinical Oncology Conferences 2017 Annual Meeting October 24-26, 2016 San Francisco, USA; Post Congress Symposium on Cancer Diagnostics May 28, 2016 Gothenberg, Sweden; Cancer-2016: A critical review on innovations in the cancer diagnosis and treatment Feb 22-24, 2016 Baltimore, USA. Affymetrix Inc , Agilent Technologies , Biomarker Pharmaceuticals Inc., Bristol-Myers Squibb Company , Roche Diagnostics Corporation, Global Lung Cancer Coalition (GLCC), Breast Cancer Welfare Association , Cancer Research Initiatives Foundation

Track 5: Cancer Nanotechnology:

Cancer nanotechnology is the burgeoning field of treatment of cancer with nanotechnology. It is applicable for cancer diagnosis, imaging, prognosis and therapy.  The nanoparticles selectively accumulate in the tumor cell by the mechanism of the enhanced permeability and retention effect. Thus, nanoparticles are suitable for delivering diagnostic and the imaging agents, chemo and gene drugs to the tumor. Nanoparticles also offer an amplification mechanism for bioanalytical detection and sensor devices for cancer markers. The tumor microenvironment is the cellular environment in which the tumor exists. The Cancer Diagnostics 2016 also focus on the surgical Oncology and its Treatment.

Recommended Conferences  Cancer Conferences | Cancer Meetings| Cancer Events:

2nd  International Conference on Prostate Cancer and Treatment May 05-07, 2016 Chicago, USA; 4th International Conference on Blood Malignancies and Treatment April 18-20, 2016 Dubai, UAE; 2nd International Conference on Antimicrobial Agents and Chemotherapy June 06-07, 2016 Dallas, USA;7th International Conference on Molecular Biomarkers & Clinical Research November 28-30, 2016 Baltimore, USA; International Conference on Pancreatic and Colorectal Cancer March 29-30, 2016 Atlanta, USA; 11th Annual Biomarkers Congress February 25-26, 2016 Manchester, UK; 2016 ARRS Lung cancer Annual Meeting April 12-16, 2016 Los Angeles, USA; NEO 16-“New and Emerging Trends In Oncology Conferences 2016, February 10-12, 2016  Hyderabad, India; EMBO | EMBL Symposium: Tumor Microenvironment and Signaling April 3-6, 2016 Heidelberg, Germany; Cancer-2016 — International Conference on Cancer Therapy April 4-6, 2016 Baltimore, USA. The ALS Association, Association for Molecular Pathology, The International Society of Oncology and Biomarkers, American Society of Clinical Oncology, Cancer Research SocietyNational Cancer Institute at the National Institutes of Health, The Canadian Cancer Society, The Swedish Cancer Society, The British Association for Cancer Research, American Brain Tumor Association, German Society for Oncological Pharmacy

Track 6:  Approaches in Cancer Therapy:

Cancer rates are daily increasing particularly in the developed world. Many cancers are associated with longevity, and as life expectancy increase the risk on patients and payers will increase. Major advances in cellular biology, genetics, pharmacology and immunology in the past ten years are beginning to be translated into progress in cancer treatment. This progress is manifested by new cell killing drugs which have recently entered clinical practice. Tumor angiogenesis as a target is being studied in several clinical trials. The emerging field of genomics and gene expression micro-arrays will provide extensive information about the biology of cancers. This is the most prestigious conference across all the Cancer Conferences and  Oncology Conferences

Recommended  Conferences  Cancer Conferences| Cancer Meetings| Cancer Events:

13th Asia-Pacific Oncologists Annual Meeting October17-19, 2016 Kuala Lumpur, Malaysia; Experts Meeting on Gynecologic Oncology May 19-21, 2016 San Antonio, USA; International Conference on Pancreatic and Colorectal Cancer March 29-30, 2016 Atlanta, USA;, 7th International Conference on Molecular Biomarkers & Clinical Research November 28-30, 2016 Baltimore, USA. International Conference on Leukemia and Bone marrow Transplantation November 10-12, 2016, Istanbul, Turkey; Personalized Diagnostics February 16-18, 2016 San Francisco, USA; International Conference on  Cancer Research, June 8-10, 2016 Lyon, France; American Society of Clinical Oncology Conferences 2017 Annual Meeting October 24-26, 2016 San Francisco, USA; Post Congress Symposium on Cancer Diagnostics May 28, 2016 Gothenberg, Sweden; Cancer-2016: A critical review on innovations in the cancer diagnosis and treatment Feb 22-24, 2016 Baltimore, USA. Affymetrix Inc , Agilent Technologies , Biomarker Pharmaceuticals Inc., Bristol-Myers Squibb Company , Roche Diagnostics Corporation, Global Lung Cancer Coalition (GLCC), Breast Cancer Welfare Association , Cancer Research Initiatives Foundation

Track 7:  Predictive Cancer Biomarkers:

A cancer biomarker can be a process substance that indicates the presence of cancer in the body. It may be a molecule secreted by tumor cells or a particular response of the body because of the presence of cancer. Biomarkers may genetic, epigenetic, proteomic, glycomic, or imaging. They can be used for cancer diagnosis, prognosis, medicine, epidemiology of cancer. Those biomarkers that are particularly associated with mutations offer a quantitative way to determine when individuals are predisposed to particular types of cancers. Mutations of genes like BRCA1 and BRCA2 are advanced breast cancer biomarkers, and mutations on genes like KRAS, p53, EGFR, erbB2 are used for colorectal, esophageal, liver, and pancreatic cancer. Cancer Diagnostics 2016 is the only conference to visit all over European Cancer Conferences which includes scientists from different areas of expertise in the field of Cancer

Recommended Conferences  Cancer Conferences| Cancer Meetings| Cancer Events:

2nd  International Conference on Prostate Cancer and Treatment May 05-07, 2016 Chicago, USA; 4th International Conference on Blood Malignancies and Treatment April 18-20, 2016 Dubai, UAE; 2nd International Conference on Antimicrobial Agents and Chemotherapy June 06-07, 2016 Dallas, USA;7th International Conference on Molecular Biomarkers & Clinical Research November 28-30, 2016 Baltimore, USA; International Conference on Pancreatic and Colorectal Cancer March 29-30, 2016 Atlanta, USA; 11th Annual Biomarkers Congress February 25-26, 2016 Manchester, UK; 2016 ARRS Lung cancer Annual Meeting April 12-16, 2016 Los Angeles, USA; NEO 16-“New and Emerging Trends In Oncology Conferences 2016, February 10-12, 2016  Hyderabad, India; EMBO | EMBL Symposium: Tumor Microenvironment and Signaling April 3-6, 2016 Heidelberg, Germany; Cancer-2016 — International Conference on Cancer Therapy April 4-6, 2016 Baltimore, USA. The ALS Association, Association for Molecular Pathology, The International Society of Oncology and Biomarkers, American Society of Clinical Oncology, Cancer Research SocietyNational Cancer Institute at the National Institutes of Health, The Canadian Cancer Society, The Swedish Cancer Society, The British Association for Cancer Research, American Brain Tumor Association, German Society for Oncological Pharmacy

Track 8: Cancer Genomics and Epigenetics:

Clinical genomics is the sequencing of genome to inform patient diagnosis and care. Clinical genomics is a new and ever-changing field. Knowledge of the human genome is far from complete, but there are already uses for genetic and genomic information at the physician’s desk. Genome sequencing is expected to have the most impact in: characterizing and detecting the genetic disease; stratifying patients for appropriate cancer treatment; and providing information about an individual’s likely response to reduce adverse drug reactions.

Recommended  Conferences  Cancer Conferences| Cancer Meetings| Cancer Events:

13th Asia-Pacific Oncologists Annual Meeting October17-19, 2016 Kuala Lumpur, Malaysia; Experts Meeting on Gynecologic Oncology May 19-21, 2016 San Antonio, USA; International Conference on Pancreatic and Colorectal Cancer March 29-30, 2016 Atlanta, USA;, 7th International Conference on Molecular Biomarkers & Clinical Research November 28-30, 2016 Baltimore, USA. International Conference on Leukemia and Bone marrow Transplantation November 10-12, 2016, Istanbul, Turkey; Personalized Diagnostics February 16-18, 2016 San Francisco, USA; International Conference on  Cancer Research, June 8-10, 2016 Lyon, France; American Society of Clinical Oncology Conferences 2017 Annual Meeting October 24-26, 2016 San Francisco, USA; Post Congress Symposium on Cancer Diagnostics May 28, 2016 Gothenberg, Sweden; Cancer-2016: A critical review on innovations in the cancer diagnosis and treatment Feb 22-24, 2016 Baltimore, USA. Affymetrix Inc , Agilent Technologies , Biomarker Pharmaceuticals Inc., Bristol-Myers Squibb Company , Roche Diagnostics Corporation, Global Lung Cancer Coalition (GLCC), Breast Cancer Welfare Association , Cancer Research Initiatives Foundation

Track 9: Cancer Treatment:

There are several cancer treatments. The types of treatment that you have will depend on the type of person and the type of cancer you have and how it is. Some people with cancer will have only one treatment. But most people have a group of treatments, such as surgery with chemotherapy and/or radiation therapy. Also have immunotherapy, targeted therapy, or hormone therapy. . This is the most prestigious conference across the world Cancer Conferences and  Oncology Conferences

Recommended Cancer Conferences | Cancer Meetings | Cancer Events:

2nd  International Conference on Prostate Cancer and Treatment May 05-07, 2016 Chicago, USA; 4th International Conference on Blood Malignancies and Treatment April 18-20, 2016 Dubai, UAE; 2nd International Conference on Antimicrobial Agents and Chemotherapy June 06-07, 2016 Dallas, USA;7th International Conference on Molecular Biomarkers & Clinical Research November 28-30, 2016 Baltimore, USA; International Conference on Pancreatic and Colorectal Cancer March 29-30, 2016 Atlanta, USA; 11th Annual Biomarkers Congress February 25-26, 2016 Manchester, UK; 2016 ARRS Lung cancer Annual Meeting April 12-16, 2016 Los Angeles, USA; NEO 16-“New and Emerging Trends In Oncology Conferences 2016, February 10-12, 2016  Hyderabad, India; EMBO | EMBL Symposium: Tumor Microenvironment and Signaling April 3-6, 2016 Heidelberg, Germany; Cancer-2016 — International Conference on Cancer Therapy April 4-6, 2016 Baltimore, USA. The ALS Association, Association for Molecular Pathology, The International Society of Oncology and Biomarkers, American Society of Clinical Oncology, Cancer Research SocietyNational Cancer Institute at the National Institutes of Health, The Canadian Cancer Society, The Swedish Cancer Society, The British Association for Cancer Research, American Brain Tumor Association, German Society for Oncological Pharmacy

Track 10: Recent Diagnostics Technologies:

An accurate and full knowledge on cancer diagnosis is the first step in developing an individualized cancer treatment strategy. When you first visit hospital, we will perform a complete array of diagnostic tests to accurately confirm your disease and plan your personal treatment. Diagnostic testing involves tests and procedures to confirm the disease and identify the tumor type, location, extent and stage. Its multidisciplinary approach allows readers to keep up-to-date with challenges and enhancement in their own as well as related fields. Cancer conferences also focused on these topics.

Recommended Conferences  Cancer Conferences| Cancer Meetings| Cancer Events:

13th Asia-Pacific Oncologists Annual Meeting October17-19, 2016 Kuala Lumpur, Malaysia; Experts Meeting on Gynecologic Oncology May 19-21, 2016 San Antonio, USA; International Conference on Pancreatic and Colorectal Cancer March 29-30, 2016 Atlanta, USA;, 7th International Conference on Molecular Biomarkers & Clinical Research November 28-30, 2016 Baltimore, USA. International Conference on Leukemia and Bone marrow Transplantation November 10-12, 2016, Istanbul, Turkey; Personalized Diagnostics February 16-18, 2016 San Francisco, USA; International Conference on  Cancer Research, June 8-10, 2016 Lyon, France; American Society of Clinical Oncology Conferences 2017 Annual Meeting October 24-26, 2016 San Francisco, USA; Post Congress Symposium on Cancer Diagnostics May 28, 2016 Gothenberg, Sweden; Cancer-2016: A critical review on innovations in the cancer diagnosis and treatment Feb 22-24, 2016 Baltimore, USA. Affymetrix Inc , Agilent Technologies , Biomarker Pharmaceuticals Inc., Bristol-Myers Squibb Company , Roche Diagnostics Corporation, Global Lung Cancer Coalition (GLCC), Breast Cancer Welfare Association , Cancer Research Initiatives Foundation

Track 11: Organ Specific Cancer:

The name of cancer is based on the location of cancer cells occur in particular organ.  There are more than 200 different types of cancer diagnosed. Among them Lung cancer, breast cancer are the most common cancer diagnosed cancer in 2015. Apart from these prostate cancers, colon cancers, bladder cancer are the most common type cancer. Depending upon the location of cancer the causes, symptoms and method of treatments varies. Carcinoma, Sarcoma, leukemia, lymphoma and melanoma are the types of cancer found in different organs. . This is the most prestigious conference across all the Cancer Conferences and  Oncology Conferences

Recommended Conferences  Cancer Conferences| Cancer Meetings| Cancer Events:

2nd International Conference on Prostate Cancer and Treatment May 05-07, 2016 Chicago, USA; 4th International Conference on Blood Malignancies and Treatment April 18-20, 2016 Dubai, UAE; 2nd International Conference on Antimicrobial Agents and Chemotherapy June 06-07, 2016 Dallas, USA;7th International Conference on Molecular Biomarkers & Clinical Research November 28-30, 2016 Baltimore, USA; International Conference on Pancreatic and Colorectal Cancer March 29-30, 2016 Atlanta, USA; 11th Annual Biomarkers Congress February 25-26, 2016 Manchester, UK; 2016 ARRS Lung cancer Annual Meeting April 12-16, 2016 Los Angeles, USA; NEO 16-“New and Emerging Trends In Oncology Conferences 2016, February 10-12, 2016  Hyderabad, India; EMBO | EMBL Symposium: Tumor Microenvironment and Signaling April 3-6, 2016 Heidelberg, Germany; Cancer-2016 — International Conference on Cancer Therapy April 4-6, 2016 Baltimore, USA. The ALS Association, Association for Molecular Pathology, The International Society of Oncology and Biomarkers, American Society of Clinical Oncology, Cancer Research SocietyNational Cancer Institute at the National Institutes of Health, The Canadian Cancer Society, The Swedish Cancer Society, The British Association for Cancer Research, American Brain Tumor Association, German Society for Oncological Pharmacy

Track 12: Global Oncologists Meeting:

The cancer study is called as Oncology. A person who specializes in the study of oncology and treating people with cancer is known as oncologist. An oncologist shows dedicative care towards treatment once a person is suffering from cancer.

There are about 2900 oncologists in Germany, and 8000 oncologists in USA, around 9500 oncologists in Europe and 1500 eminent oncologists from different parts of Asia.

Recommended Conferences Cancer Conferences| Cancer Meetings| Cancer Events:

13th Asia-Pacific Oncologists Annual Meeting July 11-13, 2016 Kuala Lumpur, Malaysia; Experts Meeting on Gynecologic Oncology May 19-21, 2016 San Antonio, USA; International Conference on Pancreatic and Colorectal Cancer March 29-30, 2016 Atlanta, USA;, 7th International Conference on Molecular Biomarkers & Clinical Research November 28-30, 2016 Baltimore, USA. International Conference on Leukemia and Bone marrow Transplantation November 10-12, 2016, Istanbul, Turkey; Personalized Diagnostics February 16-18, 2016 San Francisco, USA; International Conference on  Cancer Research, June 8-10, 2016 Lyon, France; American Society of Clinical Oncology Conferences 2017 Annual Meeting October 24-26, 2016 San Francisco, USA; Post Congress Symposium on Cancer Diagnostics May 28, 2016 Gothenberg, Sweden; Cancer-2016: A critical review on innovations in the cancer diagnosis and treatment Feb 22-24, 2016 Baltimore, USA. Affymetrix Inc , Agilent Technologies , Biomarker Pharmaceuticals Inc., Bristol-Myers Squibb Company , Roche Diagnostics Corporation, Global Lung Cancer Coalition (GLCC), Breast Cancer Welfare Association , Cancer Research Initiatives Foundation

Track 13: Cancer Clinical Trails:

Clinical trials are research studies that involve people. Understanding what they are can help you decide if a clinical trial might be an option for you. Or maybe you have a friend or family member with cancer and are wondering if a clinical trial is right for them. Depending on product type and development stage, investigators initially enroll volunteers and/or patients into small pilot studies, and subsequently conduct progressively larger scale comparative studies. Clinical trials can vary in size and cost, and they can involve a single research center or multiple centers, in one country or in multiple countries. Clinical study design aims to ensure the scientific validity and reproducibility of the results. Cancer Diagnostics 2016 is a very prestigious gathering across global Cancer Conferences.

Recommended  Conferences  Cancer Conferences| Cancer Meetings| Cancer Events:

2nd International Conference on Prostate Cancer and Treatment May 05-07, 2016 Chicago, USA; 4th International Conference on Blood Malignancies and Treatment April 18-20, 2016 Dubai, UAE; 2nd International Conference on Antimicrobial Agents and Chemotherapy June 06-07, 2016 Dallas, USA;7th International Conference on Molecular Biomarkers & Clinical Research November 28-30, 2016 Baltimore, USA; International Conference on Pancreatic and Colorectal Cancer March 29-30, 2016 Atlanta, USA; 11th Annual Biomarkers Congress February 25-26, 2016 Manchester, UK; 2016 ARRS Lung cancer Annual Meeting April 12-16, 2016 Los Angeles, USA; NEO 16-“New and Emerging Trends In Oncology Conferences 2016, February 10-12, 2016  Hyderabad, India; EMBO | EMBL Symposium: Tumor Microenvironment and Signaling April 3-6, 2016 Heidelberg, Germany; Cancer-2016 — International Conference on Cancer Therapy April 4-6, 2016 Baltimore, USA. The ALS Association, Association for Molecular Pathology, The International Society of Oncology and Biomarkers, American Society of Clinical Oncology, Cancer Research SocietyNational Cancer Institute at the National Institutes of Health, The Canadian Cancer Society, The Swedish Cancer Society, The British Association for Cancer Research, American Brain Tumor Association, German Society for Oncological Pharmacy

Cancer Diagnostics 2016  invites you to attend the Cancer Diagnostics Conference & Expo, which will be held during June 13-15, 2016 in Rome, Italy.

Cancer Diagnostics 2016 will bring  all the major players in the diagnostics that are Cancer Associations and Cancer Societies to navigate the research advancements and technologies responsible for creating immense opportunity in the industry, so that delegates have the unique opportunity to network with colleagues from different sectors and discuss new research in cancer diagnostics, including next generation sequencing, the use of clinical utility of cell-free DNA liquid biopsy, patient selection for cancer drug development, and correlative predictive markers. Oncologist will get a platform like global Cancer Conferences  to share their research and information.

Conferenceseries LLC organizes a conference series of 1000+ Global Events inclusive of 300+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.

Why to attend???

With members from around the world focused on learning about cancer and its diagnostics and the European Cancer Society this is your best opportunity to reach the largest assemblage of participants from the Oncology community. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new developments and research, and receive name recognition at this 3-day event. World-renowned speakers, the most recent techniques, developments, and the newest updates in cancer diagnostics Equipment and latest devices expo are hallmarks of this conference.

Target Audience:

  • Oncology Students, Scientists
  • Oncology Researchers
  • Oncology Faculty
  • Medical Colleges
  • Oncology institutes
  • Cancer Diagnostics Associations and Societies
  • Business Entrepreneurs
  • Training Institutes of cancer diagnosis
  • Software developing companies
  • Cancer diagnostics manufacturing Medical Devices Companies
  • Data Management Com
  • cancer genomics, bioinformatics, clinical genomics, pharmacogenomics

Conferenceseries LLC  invites you to attend the Cancer Diagnostics Conference & Expo, which will be held during June 13-15, 2016 in Rome, Italy.

Cancer Diagnostics 2016 will bring  all the major players in the diagnostics that are Cancer Associations and Cancer Societies to navigate the research advancements and technologies responsible for creating immense opportunity in the industry, so that delegates have the unique opportunity to network with colleagues from different sectors and discuss new research in cancer diagnostics, including next generation sequencing, the use of clinical utility of cell-free DNA liquid biopsy, patient selection for cancer drug development, and correlative predictive markers. Oncologist will get a platform like global Cancer Conferences  to share their research and information.

Conferenceseries LLC organizes a conference series of 1000+ Global Events inclusive of 300+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.

Why to attend???

With members from around the world focused on learning about cancer and its diagnostics and the European Cancer Society this is your best opportunity to reach the largest assemblage of participants from the Oncology community. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new developments and research, and receive name recognition at this 3-day event. World-renowned speakers, the most recent techniques, developments, and the newest updates in cancer diagnostics Equipment and latest devices expo are hallmarks of this conference.

Target Audience:

  • Oncology Students, Scientists
  • Oncology Researchers
  • Oncology Faculty
  • Medical Colleges
  • Oncology institutes
  • Cancer Diagnostics Associations and Societies
  • Business Entrepreneurs
  • Training Institutes of cancer diagnosis
  • Software developing companies
  • Cancer diagnostics manufacturing Medical Devices Companies
  • Data Management Com
  • cancer genomics, bioinformatics, clinical genomics, pharmacogenomics

Global cancer diagnostics market is expected to reach $13.1 Billion in 2020 from an estimated $7.1 Billion in 2015, growing at a CAGR panies of 12.9%. The market is dominated by North America, followed by Europe, Asia, and Rest of the World (RoW). The cancer diagnostics market in Asia is expected to grow at the highest rate from 2015 to 2020.

The In-Vitro Diagnostic Market research report evaluates the IVD market globally with respect to the revenue, growth, and industry focus in the following markets:

Global IVD market, by applications:

  • Molecular diagnostics
  • Immunoassays
  • Clinical chemistry
  • Microbiology
  • Hematology
  • Others (Flow cytometry, nephelometry, coagulation, advanced lipid testing, etc.)

                 Statistical Analysis of Universities associated Cancer Diagnosis and Research

 

Global IVD market, by types:

  • Analyzers
  • Reagents
  • Services

Global IVD market, by end-users:

  • Patient self testing
  • Laboratories (Commercial labs & physician’s office labs)
  • Hospitals
  • Universities
  • Ambulatory care

 Top Universities and hospitals related to cancer in Italy

Arcispedale S. Maria Nuova Hospital , Reggio Emilia , Italy

University Hospital San Martino- IST - National Institute for Cancer Research , Genoa, Italy

Oncological Referral Center - National Cancer Institute ,  Aviano Italy

Oncological Referral Center of Basilicata Rionero in Vulture, Italy

European Institute of Oncology Milan Italy

San Raffaele Hospital in Milan Italy

Institute of Molecular Oncology Milan Italy

Institute for Pharmacological Research Mario Negri, Milan Italy

National Institute for the Study and Treatment of Cancer Foundation ' G.Pascale ' Milan Italy

Oncology Institute Veneto Italy

Istituto Regina Elena / Regina Elena Cancer Institute, Rome Italy

Romagnolo Scientific Institute for Treatment of Cancer Italy

Institute of Oncology, Italy

The International Neuroscience Institute Hannover, Gerniar

Gustave Roussy Institute  Villejuif. Paris

 

                Hospitals associated with Cancer Diagnosis

The global cancer diagnostics market is witnessing a rapid transformation owing to several technological advancements in diagnostic platforms. Moreover, the market has seen the advent of hybrid imaging instruments with enhanced accuracy, such as PET/CT and SPECT/CT. These advancements have augmented the growth of the cancer diagnostics market. However, shortage of trained and skilled personnel poses as a restraint to the market growth of cancer diagnostics. Rise in aging population and increasing cancer cases are likely to create huge opportunity for cancer diagnostics.

The instrument-based cancer diagnostics segment accounted for the largest share of the global the cancer diagnostics market, by technology, while breast cancer accounted for the largest share of the cancer diagnostics applications market, in 2014. North America accounted for the largest share of the global cancer diagnostics market, followed by Europe, Asia, and the Rest of the World (RoW). In the coming years, the cancer diagnostics market is expected to experience the highest growth rate in the Asian region, with emphasis on India and China. These countries are expected to serve as revenue pockets for companies operating in the cancer diagnostics market.

Some of the major players in the global cancer diagnostics system market include Agilent Technologies, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Illumina, Inc. (Denmark), Becton, Dickinson and Company (U.S.),  GE Healthcare (U.K.), QIAGEN N.V.  (Netherlands), Abbott Laboratories, Inc. (U.S.), Roche Diagnostics (Switzerland), Siemens Healthcare (Germany), Philips Healthcare (U.K.), and C.R. Bard, Inc. (U.S.), among others.

                                Members Associated in Cancer Research and Development

A worldwide overview of the cancer diagnostics market, including mortality statistics and scientific views on the etiology of major types of cancer, estimates of the number of laboratories performing cancer tests, as well as ten-year test volume and sales forecasts by country. Worldwide, All Market Segments, Laboratories Performing Cancer Diagnostic Testing By Country; Worldwide, All Market Segments, Cancer Diagnostic Test Volume Forecasts By Country and Worldwide, All Market Segments, Cancer Diagnostics Sales Forecasts By Country are the three major tables provided in this research along with information on business environment, market structure, market size and growth.

                            

                        

 

Cancer Summit 2015

Conference series LLC 5th Asia-Pacific Summit on Cancer Therapy at Park Regis Brisbane, Australia during July 20-22, 2015 was organized with a focus on "Forum for a world without cancer was a great success where eminent keynote speakers from various reputed institutions made their resplendent presence and addressed the gathering.

Cancer Summit-2015 witnessed an amalgamation of peerless speakers who enlightened the crowd with their knowledge and confabulated on various newfangled topics related to the field of cancer.

Cancer Summit-2015 Organizing Committee would like to thank the Moderator of the conference, Dr. Rupinder Kaur Kanwar, Deakin University, K who contributed a lot for the smooth functioning of this event.

Conferenceseries LLC would like to convey a warm gratitude to all the Honorable guests and Keynote Speakers of Cancer Summit-2015:

Jagat R Kanwar, Deakin University, Australia

Kwok-nam Leung, The Chinese University of Hong Kong, Hong Kong

Izhak Haviv, Bar Ilan University, Israel

Pascal H G Dujif, University of Queensland, Australia

Veronica J James, Australian National University, Australia

Conferenceseries LLC on behalf of the conference, congratulates the Best Poster awardees for their outstanding performance and appreciates all the participants who put their efforts in poster presentations and sincerely wishes them success in future endeavors. We would like to thank the Poster Competition Judge Dr. Izhak Haviv, Bar Ilan University, Israel for his valuable time.

Best Poster Winners:


Conferenceseries LLC also took the privilege of felicitating Cancer Summit-2015 Organizing Committee, Editorial Board Members of Journals of Cancer Science & Therapy, Journal of Carcinogenesis & Mutagenesis and Journal of Integrative Oncology, Keynote Speakers, Chair and Co-Chairs and Moderator whose support made conference a great success.

With the enormous feedback from the participants and supporters of Cancer Summit-2015, Conferenceseries LLC is glad to announce


Past Reports  Proceedings  Gallery  

Chemotherapy-2015

Over thousands of scholars from the field of Chemotherapy stepped away from their nations last Tuesday, August 2nd, 2015to take part in an ostentatious event “International Conference on Antimicrobial Agents and Chemotherapy” August 04-06, 2015, in Valencia, Spain. The conference was organized around a single theme “Emerging techniques and advancements in the field of chemotherapy which comprised of 06 tracks with knowledge oriented presentations igniting young minds in the crowd.

The Conference provided a rostrum for interaction among keynotes, chair & co-chairs, plenary speakers, poster presentees, young research fellows & delegates and to share their experiences, ideas & research, thus helping to generate a new way of looking at Cancer treatments.

Conference began with the welcome message given by our moderator Dr. Emil Toma, University of Montreal, USA, followed by a Keynote series of well-known speakers:

  • Dr. Emil Toma, University of Montreal, USA.
  • Dr. Didier Coquoz, Copexis, Switzerland.
  • Dr. Hiroyuki Osada, RIKEN Center for Sustainable Resource Science, Japan.

The session was chaired by Dr. Emil Toma, University of Montreal, USA, preceded with paramount Oral Presentations. The Conference also witnessed an amalgamation of eminent speakers like:

  • Junjun Qiu, Obstetrics and Gynecology Hospital of Fudan University, China.
  • Helene Castel, Universite de Rouen, France
  • Paula Sabbo Bernado, Brazilian National Cancer Institute, Brazil.

The Conference also provided a platform for a grandiose Workshop by:

  • Isabel Portero Sanchez, Universidad Complutense & BIOHOPE Scientific Solutions, Spain
  • Dirk Buscher, Gri-Cel S.A. Spain
  • Eva Martin Becerra, Gradocell& IMMPULSO Medical Sciences, Spain

The second day session was chaired and Keynote speech was given by:

  • Dr. Hiroyuki Osada, RIKEN Center for Sustainable Resource Science, Japan

The session was preceded by Oral Presentations by:

  • Dr. Hiroyuki Osada, RIKEN Center for Sustainable Resource Science, Japan
  • Dr. Minoru Yoshida, RIKEN Center for Sustainable Resource Science, Japan
  • Natalia Martins, Polytechnic Institute of Braganca, Portugal

A Global Platform was given to students to explore their research work under the category Young Research Forum:

  • Bin Li, University of Hong Kong, China
  • Wen WenXu, University of Hong Kong, China
  • Natalia Martins, Polytechnic Institute of Braganca, Portugal
  • Maude Loignon, University of Montreal, Canada

Conferenceseries LLC acknowledges all the Organizing Committee Members, Moderator, Chair and Editorial Board Members of OMICS group Journals, Speakers, Students, Delegates and Media Partners in making this event a great success. We are also obliged to various government authorities, company representatives and other eminent personalities who supported the conference by facilitating active discussion forums. We sincerely thank the Organizing Committee Members, for their gracious presence, support and assistance.

 


Past Reports  Proceedings  Gallery  

Radiology-2015

Conferenceseries LLC 3rd International Conference on Radiology & Imaging at Toronto Airport Marriott Hotel, Toronto, Canada during August 24-26, 2015 was organized with a focus on Critical Review on “Advanced Trends in Radiology and Imaging” was a great success where eminent keynote speakers from various reputed institutions made their resplendent presence and addressed the gathering.

Radiology-2015 witnessed an amalgamation of peerless speakers who enlightened the crowd with their knowledge and confabulated on various newfangled topics related to the field of Radiology & Imaging.

Radiology-2015 Organizing Committee would like to thank the Moderator of the conference,Dr.Sangeeta Taneja, Indraprastha Apollo Hospitals, India who contributed a lot for the smooth functioning of this event.

OMICS Group International would like to convey a warm gratitude to all the Honorable guests and Keynote Speakers of Radiology-2015:

Richard P Hill, University of Toronto, Canada
Mark G Benz, Engineering Horizons International, USA
Radim Jancalek, St. Anne’s University Hospital, Czech Republic

Mitchell S Albert, Lakehead University, Canada
 

Confernceseries LLC on behalf of the conference, appreciates all the participants who put their efforts in poster presentations and sincerely wishes them success in future endeavors.

Conferenceseries LLC also took the privilege of felicitating Radiology-2015 Organizing Committee, Editorial Board Members of OMICS Journal of Radiology and Journal of Nuclear Medicine and Radiation Therapy, Keynote Speakers, Chair and Co-Chairs and Moderator whose support made conference a great success.

With the enormous feedback from the participants and supporters of Radiology-2015, OMICS International Conferences is glad to announce


Past Reports  Proceedings  Gallery  

Prostate Cancer-2015

Prostate Cancer-2015 witnessed an amalgamation of peerless speakers who enlightened the crowd with their knowledge and confabulated on various newfangled topics related to the field of prostate. Qun Lu from East Carolina University, USA presented a paper on “Urine biomarkers for prostate cancer detection”; Veronica J James from Australian National University, Australia presented a paper on “Why wait till it is too late”; Taisei Nomura from Osaka University, Japan presented a paper on “Establishment of prostate cancer and benign prostatic hyperplasia PDX (patient-derived xenograft) in super-SCID mice”; Jiao Zhang from East Carolina University, USA presented a paper on “Development of prostatic exosomal protein (PSEP) lateral flow chromatographic strips for detection of chronic prostatitis”; Joanna Dulinska-Litewka from Jagiellonian University Medical College, Poland presented a paper on “Increased AKT signaling resulting from the loss of androgen responsiveness in prostate cancer”; Fahri Saatcioglu from University of Oslo, Norway presented a paper on “Divergent androgen regulation of unfolded protein response pathways drives prostate cancer”; Steve Assinder from Andrology Research Group, Australia presented a paper on “Oxytocin in prostate pathology. Is there a sinister side to the hormone of love”; Nathalie Picollet-D’hahan from CEA/DSV/iRTSV/BGE/Biomics, France presented a paper on “Emerging nano and microtechnologies in prostate cancer research: New tools for diagnosis & biomarkers discovery”.

 

Prostate Cancer-2015 dealt with the diagnosis, prevention, and treatment of diseases of the Prostate, Benign Prostatic Hyperplasia, Prostatitis, Radical Prostatectomy including Prostate Cancer side effects and management.

Dr. Lucia Languino, Thomas Jefferson University, USA conducted a workshop on Molecular mechanisms of prostate cancer progression on June 22, 2015, in connection with this conference and as a curtain raiser to the topic.

 

Poster presentations were presented by students and the best posters were awarded to Charlotte Lavallee from University of Copenhagen, Denmark and Nanami Kikuchi from University of Central Florida, USA

 

All the papers presented at the Prostate Cancer-2015 will be published in the proceedings of the Journal of Cancer Science and Therapy

 


Past Reports  Proceedings  Gallery  

Breast Cancer-2015

Thanks to all of our wonderful speakers, conference attendees and Sponsors, Breast Cancer-2015 Conference was our best ever!

World Congress on Breast Cancer, hosted by the OMICS Group was held during August 03-05, 2015 Birmingham, UK at Hilton Birmingham Metropole Hotel, Birmingham, UK with the theme “New Discoveries for Better Diagnosis and Treatments for Breast Cancer and to bring Awareness”. Benevolent response and active participation was received from the Editorial Board Members of OMICS Group Journals as well as from the Professors, Surgeons, Oncologists, Biostatisticians, Healthcare Professionals, Industry experts, Researchers and Students from the fields Breast Cancer-2015, who made this event successful.

The meeting was carried out through various sessions, in which the discussions were held on the following major scientific tracks:

Biology of Breast Cancer

Breast Cancer Tests: Screening, Diagnosis and Monitoring

HER2 Positive and Other Types of Breast Cancers

Breast Cancer Therapy

Chemotherapy for Breast Cancer

Breast Cancer Immunotherapy & Radiation Therapy

Innovative Therapeutic Approaches in Breast Cancer

Breast Cancer Treatment Side Effects

Optimal Breast Cancer Pathology – Organization

 

The conference was initiated with a series of lectures delivered by both Honorable Guests and members of the Keynote forum. The list included:

Shahla Masood
University of Florida College of Medicine-Jacksonville, USA

Raj Kumar
The Commonwealth Medical College, USA 

Tibor Tot
European Society of Pathology, Sweden

Amila Orucevic
The University of Tennessee Medical Center, USA  

Yvonne Paterson
University of Pennsylvania, USA

Aysegul A. Sahin
The University of Texas MD Anderson Cancer Center, USA

Robert-Alain Toillon
Universite Lille 1, France

Philippa D. Darbre
University of Reeding, UK

S Sahni
Indraprastha Apollo Hospital, India

Peter Weightman
University of Liverpool, UK

Esmaeil Akbari
Shahid Beheshti University of Medical Sciences, Iran

Lei Huo
The University of Texas MD Anderson Cancer Center, USA

Stephen Assinder
University of Sydney, Australia


Past Reports  Gallery  

sponsor

Want to Differentiate your company from your competitors and broaden your competitive edge?

Use our global platform of 3000+ Global Events

  • 25 Million+ Visitors to our Global website (conferenceseries.com)
  • 20000+ Unique Visitors per conference
  • 60000+ Page views per conference

For customized sponsorship opportunities at our conferences, or to place an ad on our websites, contact at sponsors@conferenceseries.com or call at: +1-650-268-9744

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date June 13-15, 2016
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Day 1 Day 2
Poster Opportunity Available

Media Partners

Conferenceseries Destinations